Publications
Dogs with congenital porto-systemic shunting (cPSS) and hepatic encephalopathy have higher serum concentrations of C-reactive protein than asymptomatic dogs with cPSS. Gow AG, Marques AI, Yool DA, Crawford K, Warman SM, Eckersall PD, Jalan R, Mellanby RJ. Metabolic brain disease 2012 E-pub 23 February.
Identification of tumour initiating cells in feline head and neck squamous cell carcinoma and evidence for gefitinib induced epithelial to mesenchymal transition. Pang LY, Bergkvist GT, Cervantes-Arias A, Yool DA, Muirhead R Argyle DJ. Veterinary Journal, 2012 E-pub 16 February.
A prospective study of basal insulin concentrations in dogs with congenital portosystemic shunts. Collings AJ, Gow AG, Marques A, Yool D, Furneaux R, Mellanby R, Watson PJ. Journal of Small Animal Practice 2012 Apr;53(4):228-33.
Nanocrystalline silver dressing in combination with sub-atmospheric pressure therapy for wound management following radiation therapy and surgical excision of a suspected feline injection-site sarcoma. Woods S, de Castro Marques A, Argyle SA, Renwick M, Yool, DA. Journal of Feline Medicine and Surgery 2012 14(3): 214-218
An unusual morphology of patent ductus arteriosus in a dog. Das S, del Pozo J, French AT, Self I, Yool DA Journal of Small Animal Practice 2011 In Press.
Chronic gastric instability and presumed incomplete volvulus in dogs. Paris JK, Yool DA, Reed N, Ridyard AE, Chandler ML, Simpson JW. Journal of Small Animal Practice 2011 52(12): 651-655
Retained Surgical Swabs in 13 dogs – a case series. Forster K., Anderson D, Yool DA, Wright C, Burrow R. Veterinary Record 2011 169(13): 337-U52
Expression of epidermal growth factor receptor (EGFR) and Ki67 in feline oral squamous cell carcinomas (FOSCC). Bergkvist GT, Argyle DJ, Morrison L, Macintyre N, Hayes A, Yool DA. Vet Comp Oncol. 2011 Jun;9(2):106-17.
Epidermal growth factor receptor as a therapeutic target in veterinary oncology. Bergkvist GT, Yool DA. Vet Comp Oncol. 2011 Jun;9(2):81-94.
Studies on the inhibition of feline EGFR in squamous cell carcinoma: Enhancement of radiosensitivity and rescue of resistance to small molecule inhibitors.Bergkvist GT, Argyle DJ, Pang LY, Muirhead R, Yool DA. Cancer Biol Ther. 2011 Jun 1;11(11):927-37.
Delayed-onset urinary incontinence in five female dogs with ectopic ureters.
Thomas PC, Yool DA. J Small Anim Pract. 2010 Apr;51(4):224-6.
Assessment of the incidence of GDV following splenectomy in dogs. Goldhammer MA, Haining H, Milne EM, Shaw DJ, Yool DA. J Small Anim Pract. 2010 Jan;51(1):23-8.
Whole blood manganese concentrations in dogs with congenital portosystemic shunts.
Gow AG, Marques AI, Yool DA, Duncan A, Mellanby RJ.
J Vet Intern Med. 2010 Jan-Feb;24(1):90-6.
The use of porcine small-intestinal submucosa for abdominal wall reconstruction--a clinical case.
de Castro Marques AI, Hipwell F, Yool DA.
J Small Anim Pract. 2009 Nov;50(11):619-23.
Imaging diagnosis--congenital venous aneurysm of the left external jugular vein.
Routh CE, Hagen RU, Else RW, Strachan FA, Yool DA.
Vet Radiol Ultrasound. 2009 Sep-Oct;50(5):506-8.
Sublingual salivary gland sialolithiasis in a dog.
Ryan T, Welsh E, McGorum I, Yool D.
J Small Anim Pract. 2008 May;49(5):254-6.
Simultaneous bilateral caudal superficial epigastric skin flaps in a cat. Woods S, de Castro Marques AI, Yool DA. Veterinary Record 2009 164(14): 434-435
Oligodendroglial modulation of fast axonal transport in a mouse model of hereditary spastic paraplegia.
Edgar JM, McLaughlin M, Yool D, Zhang SC, Fowler JH, Montague P, Barrie JA, McCulloch MC, Duncan ID, Garbern J, Nave KA, Griffiths IR.
J Cell Biol. 2004 Jul 5;166(1):121-31.
Phenotypic analysis of mice deficient in the major myelin protein MOBP, and evidence for a novel Mobp isoform.
Yool D, Montague P, McLaughlin M, McCulloch MC, Edgar JM, Nave KA, Davies RW, Griffiths IR, McCallion AS. Glia. 2002 Sep;39(3):256-67.
Evidence for possible interactions between PLP and DM20 within the myelin sheath.
McLaughlin M, Hunter DJ, Thomson CE, Yool D, Kirkham D, Freer AA, Griffiths IR. Glia. 2002 Jul;39(1):31-6.
Patients lacking the major CNS myelin protein, proteolipid protein 1, develop length-dependent axonal degeneration in the absence of demyelination and inflammation.
Garbern JY, Yool DA, Moore GJ, Wilds IB, Faulk MW, Klugmann M, Nave KA, Sistermans EA, van der Knaap MS, Bird TD, Shy ME, Kamholz JA, Griffiths IR.
Brain. 2002 Mar;125(Pt 3):551-61.
Observations on the structure of myelin lacking the major proteolipid protein.
Yool D, Klugmann M, Barrie JA, McCulloch MC, Nave KA, Griffiths IR.
Neuropathol Appl Neurobiol. 2002 Feb;28(1):75-8.
Myelin proteolipid proteins promote the interaction of oligodendrocytes and axons.
Yool DA, Klugmann M, McLaughlin M, Vouyiouklis DA, Dimou L, Barrie JA, McCulloch MC, Nave KA, Griffiths IR.
J Neurosci Res. 2001 Jan 15;63(2):151-64.
The proteolipid protein gene and myelin disorders in man and animal models.
Yool DA, Edgar JM, Montague P, Malcolm S.
Hum Mol Genet. 2000 Apr 12;9(6):987-92.
Axonal swellings and degeneration in mice lacking the major proteolipid of myelin.
Griffiths I, Klugmann M, Anderson T, Yool D, Thomson C, Schwab MH, Schneider A, Zimmermann F, McCulloch M, Nadon N, Nave KA.
Science. 1998 Jun 5;280(5369):1610-3.